The pulmonary surfactant protein A (SP-A) is a constitutively expressed immune-protective
collagenous lectin (collectin) in the lung. It binds to the cell membrane of immune cells and …

The spike glycoprotein (S) of the SARS‐CoV‐2 virus surface plays a key role in receptor
binding and virus entry. The S protein uses the angiotensin converting enzyme (ACE2) for …

SARS-CoV-2 entrance to the host cells is started by the interaction between receptor binding
domain (RBD) of the spike (S) protein on the virus with the angiotensin-converting enzyme 2 …

SARS-CoV-2, responsible for the COVID-19 pandemic, invades host cells via its spike
protein, which includes critical binding regions, such as the receptor-binding domain (RBD) …

The global outbreak of COVID-19 (Coronavirus Disease 2019) caused by SARS-CoV-2
(Severe Acute Respiratory Syndrome caused by Coronavirus 2) began in December 2019 …

The SARS-CoV-2 virus has caused a pandemic and is public health emergency of
international concern. As of now, no registered therapies are available for treatment of …

Many key residues, which mediate the interaction between SARS-CoV2 spike glycoprotein
(S protein) and human ACE2 receptor, have been reviewed using the SARS-CoV2 S spike …

The SARS-CoV-2 has caused more than 2,000 deaths as of 20 February 2020 worldwide
but there is no approved effective drug. The SARS-CoV-2 spike (S) glycoprotein is a key …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). As of October 21, 2020, more than 41.4 million confirmed cases …

The coronavirus disease-2019 (COVID-19) pandemic, caused by the pathogen severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), started in China during late 2019 and …